Barasertib (AZD1152-HQPA)

別名: AZD2811, INH-34, Barasertib-HQPA , Defosbarasertib 中文名稱：巴拉塞替

目錄號(hào)：S1147 Purity: 99.98%

Defosbarasertib (AZD1152-HQPA, AZD2811, INH-34, Barasertib-HQPA) 是一種高度選擇性的Aurora B抑制劑，無細(xì)胞試驗(yàn)中IC50為0.37 nM，作用于Aurora B比作用于Aurora A選擇性高3700倍左右。

Barasertib (AZD1152-HQPA) Chemical Structure

CAS: 722544-51-6

規(guī)格	價(jià)格	庫存
10mM (1mL in DMSO)	1375.46	現(xiàn)貨
5mg	976.12	現(xiàn)貨
25mg	3169.53	現(xiàn)貨
200mg	7944.3	現(xiàn)貨
1g	12039.3	現(xiàn)貨
更大包裝有超大折扣
400-668-6834 info@selleck.cn

產(chǎn)品質(zhì)控

批次：純度： 99.98%

99.98

Barasertib (AZD1152-HQPA)相關(guān)產(chǎn)品

相關(guān)靶點(diǎn)	Aurora A Aurora B Aurora C Aurora B	點(diǎn)擊展開
相關(guān)產(chǎn)品	Alisertib (MLN8237) Tozasertib (VX-680) ZM 447439 MLN8054 Hesperadin Danusertib (PHA-739358) MK-5108 TCS7010 (Aurora A Inhibitor I) AMG-900 PHA-680632 SNS-314 CCT137690 GSK1070916 CYC116 TAK-901 CCT129202 SNS-314 Mesylate LY3295668 SP-96	點(diǎn)擊展開
相關(guān)化合物庫	激酶抑制劑庫 PI3K/Akt 抑制劑庫 MAPK抑制劑庫 DNA損傷/ DNA修復(fù)化合物庫細(xì)胞周期化合物庫	點(diǎn)擊展開

細(xì)胞實(shí)驗(yàn)數(shù)據(jù)示例

細(xì)胞系	實(shí)驗(yàn)類型	給藥濃度	孵育時(shí)間	活性描述	文獻(xiàn)信息
BT474	Growth Inhibition Assay	0-10000 nM	2-5 d	IC50=8 nM	20175926
MDA-MB-231	Growth Inhibition Assay	0-10000 nM	2-5 d	IC50=105 nM	20175926
MDA-MB-468	Growth Inhibition Assay	0-10000 nM	2-5 d	IC50=14 nM	20175926
MDA-MB-435	Growth Inhibition Assay	0-10000 nM	2-5 d	IC50=125 nM	20175926
L450	Apoptosis Assay	500 nM	0-72 h	induces apoptosis in a time-dependent manner	21371446
HDLM-2	Apoptosis Assay	500 nM	0-72 h	induces apoptosis in a time-dependent manner	21371446
KM-H2	Apoptosis Assay	500 nM	0-72 h	induces apoptosis in a time-dependent manner	21371446
L428	Apoptosis Assay	500 nM	0-72 h	induces apoptosis in a time-dependent manner	21371446
Daudi?	Apoptosis Assay	500 nM	0-72 h	induces apoptosis in a time-dependent manner	21371446
Raji	Apoptosis Assay	500 nM	0-72 h	induces apoptosis in a time-dependent manner	21371446
Ramos	Apoptosis Assay	500 nM	0-72 h	induces apoptosis in a time-dependent manner	21371446
BJAJ	Apoptosis Assay	500 nM	0-72 h	induces apoptosis in a time-dependent manner	21371446
L450	Growth Inhibition Assay	500 nM	0-72 h	inhibits cell growth	21371446
HDLM-2	Growth Inhibition Assay	500 nM	0-72 h	inhibits cell growth	21371446
KM-H2	Growth Inhibition Assay	500 nM	0-72 h	inhibits cell growth	21371446
L428	Growth Inhibition Assay	500 nM	0-72 h	inhibits cell growth	21371446
Daudi?	Growth Inhibition Assay	500 nM	0-72 h	inhibits cell growth significantly	21371446
Raji	Growth Inhibition Assay	500 nM	0-72 h	inhibits cell growth significantly	21371446
Ramos	Growth Inhibition Assay	500 nM	0-72 h	inhibits cell growth significantly	21371446
BJAJ	Growth Inhibition Assay	500 nM	0-72 h	inhibits cell growth significantly	21371446
L540	Function Assay	500 nM	0-72 h	inhibits Aurora B kinase	21371446
Daudi?	Function Assay	500 nM	0-72 h	inhibits Aurora B kinase	21371446
Ramos	Function Assay	500 nM	0-72 h	inhibits Aurora B kinase	21371446
LNCaP	Function Assay	50 nM	48 h	induces micronuclei with aneugenic mechanism	25277659
LNCaP	Apoptosis Assay	0-500 nM	48?h	induces apoptotic cell death through caspase-3 upregulation	25277659
LNCaP	Growth Inhibition Assay	0-500 nM	48?h	IC50=25 nM	25277659
MDA-MB-361	Growth Inhibition Assay	0-10000 nM	2-5 d	IC50=70 nM	20175926
HER18	Growth Inhibition Assay	0-10000 nM	2-5 d	IC50=20 nM	20175926
HER18	Apoptosis Assay	100 nM	0/24/48 h	induces apoptosis and reduces clonogenic potential	20175926
MDA-MB-231	Apoptosis Assay	105 nM	0/24/48 h	induces apoptosis and reduces clonogenic potential	20175926
JHH-1	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=17.4±1.0 nM	19913935
JHH-2	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=218.0±10.8 nM	19913935
JHH-4	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=155.6±16.8 nM	19913935
HuH-1	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=27.3±5.0 nM	19913935
HuH-6	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=3.7±0.6 nM	19913935
HuH-7	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=6.8±0.3 nM	19913935
HLE	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=45.9±6.4 nM	19913935
HLF	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=126.1±12.2 nM	19913935
PLC/PRF/5	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=76.9±9.9 nM	19913935
SK-Hep1	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=21.9±1.2 nM	19913935
Hep3B	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=7.6±1.2 nM	19913935
HepG2	Growth Inhibition Assay	0.3–1000?nM	72 h	EC50=14.7±1.7 nM	19913935
Ramos	Apoptosis Assay	25/50/100 nM	48 h	increases the levels of the cleaved forms of PARP and caspase 3	19823168
Daudi?	Apoptosis Assay	25/50/100 nM	48 h	increases the levels of the cleaved forms of PARP and caspase 3	19823168
BALM-14	Apoptosis Assay	12.5/25/50 nM	48 h	increases the levels of the cleaved forms of PARP and caspase 3	19823168
BALM-27	Apoptosis Assay	12.5/25/50 nM	48 h	increases the levels of the cleaved forms of PARP and caspase 3	19823168
NB4	Growth Inhibition Assay	0.01/0.1/1 μM	48 h	inhibits cell growth significantly	18367484
HeLa	Function Assay	1 uM	24 hrs	Inhibition of aurora B autophosphorylation in human HeLa cells at 1 uM after 24 hrs by Western blotting	20684549
HCT116	Growth Inhibition Assay			EC50=11±3.3 nM	21245090
SW620	Growth Inhibition Assay			EC50=10±2.1 nM	21245090
點(diǎn)擊查看更多細(xì)胞系數(shù)據(jù)

生物活性

產(chǎn)品描述

靶點(diǎn)

Aurora B ^[1]
(Cell-free assay)

0.37 nM

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
臨床試驗(yàn)信息 (data from https://clinicaltrials.gov, updated on 2024-05-22)
NCT02579226	Completed	Advanced Solid Tumours	AstraZeneca	October 28 2015	Phase 1

參考文獻(xiàn)
[1] Oser, Matthew G et al. Cancer discovery vol. 9,2 (2019): 230-247. [2] Yang J, et al. Blood.?2007 Sep 15;110(6):2034-40.

參考文獻(xiàn)

[1] Oser, Matthew G et al. Cancer discovery vol. 9,2 (2019): 230-247.
[2] Yang J, et al. Blood.?2007 Sep 15;110(6):2034-40.

化學(xué)信息&溶解度

分子量	507.56	分子式	C₂₆H₃₀FN₇O₃
CAS號(hào)	722544-51-6	SDF	Download Barasertib (AZD1152-HQPA) SDF
Smiles	CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO
儲(chǔ)存條件(自收到貨起)	3年-20°C粉狀	儲(chǔ)備液保存和期限建議分裝儲(chǔ)備液，避免反復(fù)凍融！	1年-80°C溶于溶劑
儲(chǔ)存條件(自收到貨起)	3年-20°C粉狀	儲(chǔ)備液保存和期限建議分裝儲(chǔ)備液，避免反復(fù)凍融！	1個(gè)月-20°C溶于溶劑

體外溶解度
批次：

DMSO : 100 mg/mL ( (197.02 mM) ；DMSO吸濕會(huì)降低化合物溶解度，請(qǐng)使用新開封DMSO)

Water : Insoluble

Ethanol : Insoluble

DMSO : 100 mg/mL ( (197.02 mM) ；DMSO吸濕會(huì)降低化合物溶解度，請(qǐng)使用新開封DMSO)

Water : Insoluble

Ethanol : Insoluble

DMSO : 102 mg/mL ( (200.96 mM) ；DMSO吸濕會(huì)降低化合物溶解度，請(qǐng)使用新開封DMSO)

Ethanol : 3 mg/mL (5.91 mM)

Water : Insoluble

DMSO : 100 mg/mL ( (197.02 mM) ；DMSO吸濕會(huì)降低化合物溶解度，請(qǐng)使用新開封DMSO)

Water : Insoluble

Ethanol : Insoluble

DMSO : 100 mg/mL ( (197.02 mM) ；DMSO吸濕會(huì)降低化合物溶解度，請(qǐng)使用新開封DMSO)

Water : Insoluble

Ethanol : Insoluble

摩爾濃度計(jì)算器

體內(nèi)溶解度
批次：

現(xiàn)配現(xiàn)用，請(qǐng)按從左到右的順序依次添加，澄清后再加入下一溶劑

動(dòng)物體內(nèi)配方計(jì)算器

實(shí)驗(yàn)計(jì)算

摩爾濃度計(jì)算器

質(zhì)量	濃度	體積	分子量
=	×	×

稀釋計(jì)算器分子量計(jì)算器

動(dòng)物體內(nèi)配方計(jì)算器（澄清溶液）

第一步：請(qǐng)輸入基本實(shí)驗(yàn)信息（考慮到實(shí)驗(yàn)過程中的損耗，建議多配一只動(dòng)物的藥量）

給藥劑量 mg/kg 動(dòng)物平均體重 g 每只動(dòng)物給藥體積 μL 動(dòng)物數(shù)量只

第二步：請(qǐng)輸入動(dòng)物體內(nèi)配方組成（配方適用于不溶于水的藥物；不同批次藥物配方比例不同，請(qǐng)聯(lián)系Selleck為您提供正確的澄清溶液配方）

% DMSO + % + % Tween 80 + % ddH2O

%DMSO+ %

計(jì)算結(jié)果：

工作液濃度： mg/ml；

DMSO母液配制方法： mg 藥物溶于μL DMSO溶液（母液濃度mg/mL，注：如該濃度超過該批次藥物DMSO溶解度，請(qǐng)先聯(lián)系Selleck）；

體內(nèi)配方配制方法：取μL DMSO母液，加入μL PEG300，混勻澄清后加入μL Tween 80，混勻澄清后加入μL ddH₂O，混勻澄清。

體內(nèi)配方配制方法：取μL DMSO母液，加入μL Corn oil，混勻澄清。

注意：1. 首先保證母液是澄清的；
2.一定要按照順序依次將溶劑加入，進(jìn)行下一步操作之前必須保證上一步操作得到的是澄清的溶液，可采用渦旋、超聲或水浴加熱等物理方法助溶。

技術(shù)支持

在訂購、運(yùn)輸、儲(chǔ)存和使用我們的產(chǎn)品的任何階段，您遇到的任何問題，均可以通過撥打我們的熱線電話400-668-6834，或者技術(shù)支持郵箱tech@selleck.cn，直接聯(lián)系到我們。我們會(huì)在24小時(shí)內(nèi)盡快聯(lián)系您。

操作手冊(cè)

如果有其他問題，請(qǐng)給我們留言。

* 必填項(xiàng)

常見問題及建議解決方法

問題 1:
Can you let me know what solvent I can use for Barasertib, cat # S1147, for in vivo use? (IP injection in mice)

回答：
S1147 Barasertib (AZD1152-HQPA) can be dissolved in 30% PEG400/0.5% Tween80/5% Propylene glycol at 30mg/ml as a clear solution. Usually, when prepare the solution, we will add organic solvents first, then add Tween 80, then water. But this compound can not dissolve in 30% PEG400/0.5% Tween80/5% Propylene glycol clearly. After water was added, it became a clear solution.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Barasertib (AZD1152-HQPA)

產(chǎn)品質(zhì)控

Barasertib (AZD1152-HQPA)相關(guān)產(chǎn)品

相關(guān)信號(hào)通路圖

細(xì)胞實(shí)驗(yàn)數(shù)據(jù)示例

生物活性

化學(xué)信息&溶解度

實(shí)驗(yàn)計(jì)算

技術(shù)支持

常見問題及建議解決方法